Challenges in oncology - Case 3. Depigmentation in a chronic myeloid leukemia patient treated with STI-571

被引：37

作者：

Raanani, P ^{[1
]}

Goldman, JM

Ben-Bassat, I

机构：

[1] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel

[2] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel

[3] Hammersmith Hosp, London, England

[4] Univ London Imperial Coll Sci & Technol, Sch Med, London, England

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2002年 / 20卷 / 03期

关键词：

D O I：

10.1200/JCO.2002.20.3.869

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：869 / 870

页数：2

共 8 条

[1]

Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139

[2]

DESPAIN JD, 1992, CHEMOTHERAPY SOURCE, P531

[3]

DIPPEL E, 1995, BRIT J DERMATOL, V132, P182

[4]

HALABAN R, 1993, J INVEST DERMATOL, V100, pS176, DOI 10.1111/1523-1747.ep12465140

[5] Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor [J].

Heinrich, MC ;

Griffith, DJ ;

Druker, BJ ;

Wait, CL ;

Ott, KA ;

Zigler, AJ .

BLOOD, 2000, 96 (03) :925-932

[6]

Hou L, 2000, DEVELOPMENT, V127, P5379

[7] COORDINATED MESSENGER-RNA EXPRESSION OF C-KIT WITH TYROSINASE AND TRP-1 IN MELANIN PIGMENTATION OF NORMAL AND MALIGNANT HUMAN MELANOCYTES AND TRANSIENT ACTIVATION OF TYROSINASE BY KIT/SCF-R [J].

LUO, D ;

CHEN, H ;

SEARLES, G ;

JIMBOW, K .

MELANOMA RESEARCH, 1995, 5 (05) :303-309

[8] A novel KIT mutation results in piebaldism with progressive depigmentation [J].

Richards, KA ;

Fukai, K ;

Oiso, N ;

Paller, AS .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 44 (02) :288-292

← 1 →